share_log

Stifel Maintains Buy on Exact Sciences, Lowers Price Target to $82

Benzinga ·  Aug 1 10:34  · Ratings

Stifel analyst Daniel Arias maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $100 to $82.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment